Invention Grant
- Patent Title: Modulation of hepatitis B virus (HBV) expression
- Patent Title (中): 调控乙型肝炎病毒（HBV）表达
-
Application No.: US14137111Application Date: 2013-12-20
-
Publication No.: US09034841B2Publication Date: 2015-05-19
- Inventor: Eric E. Swayze , Susan M. Freier , Michael L. McCaleb
- Applicant: Isis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Main IPC: C12N15/113
- IPC: C12N15/113
Abstract:
Disclosed herein are antisense compounds and methods for decreasing HBV mRNA, DNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate HBV-related diseases, disorders or conditions.
Public/Granted literature
- US20140107184A1 MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION Public/Granted day:2014-04-17
Information query
IPC分类:
